Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Beam Therapeutics (BEAM) Preferred Dividend Payments (2019 - 2020)

Beam Therapeutics (BEAM) has disclosed Preferred Dividend Payments for 2 consecutive years, with $1.3 million as the latest value for Q1 2020.

  • Quarterly Preferred Dividend Payments fell 56.9% to $1.3 million in Q1 2020 from the year-ago period, while the trailing twelve-month figure was $1.3 million through Dec 2020, down 89.96% year-over-year, with the annual reading at $1.3 million for FY2020, 89.96% down from the prior year.
  • Preferred Dividend Payments for Q1 2020 was $1.3 million at Beam Therapeutics, down from $3.3 million in the prior quarter.
  • The five-year high for Preferred Dividend Payments was $3.3 million in Q4 2019, with the low at $1.3 million in Q1 2020.